Dr. Helena Chang is one of the nation’s top cancer surgeons. She received her PhD in Immunology and Microbiology from Temple University in 1975 and took advanced fellowship training in studying the regulatory mechanisms controlling cancer growth.
Her rigorous training in cancer research also led her to realize the importance of combining the research technologies with medical knowledge to advance cancer treatment. She devoted the next decade to completing an MD at Temple University School of Medicine, resident training in surgery at Episcopal Hospital, and fellowship training in surgical oncology from Memorial Sloan-Kettering Cancer Center.
In 1997, she was appointed to the position of Director of the Revlon/UCLA Breast Center. Her vision of combining science and practice was implemented to foster constant advancement in breast cancer diagnosis, treatment and prevention.
Dr. Chang’s research, which received extensive funding from the NCI, NIH and private philanthropy, focused on three challenges: defining breast cancer biomarkers for early detection and tailored drug treatment; developing a breast cancer vaccine for treatment prevention; and developing new local treatment to minimize disfigurement resulting from conventional surgery.
Dr. Chang currently serves on the editorial boards of several prestigious medical journals and consults with the Summus Medical Advisory Board. She has been recognized with numerous honors throughout her career, including “America’s Top Doctors® for Cancer.”